Feature Channels: Pharmaceuticals

Filters close
Released: 24-Aug-2022 3:20 PM EDT
American Society of Anesthesiologists Hosts ANESTHESIOLOGY® 2022
American Society of Anesthesiologists (ASA)

Adults who use cannabis consume more opioids after surgery. Reducing noise in the operating room (OR) improves postoperative behavior in children, including decreased temper tantrums and fussiness about eating. Minorities are less likely to have patient-centered end-of-life care. These are among the important research findings being presented at ANESTHESIOLOGY® 2022, the annual meeting of the American Society of Anesthesiologists (ASA), Oct. 21-25 in New Orleans.

Newswise: Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near Death Experiences
Released: 24-Aug-2022 2:55 PM EDT
Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near Death Experiences
Johns Hopkins Medicine

In a survey study of more than 3,000 adults, Johns Hopkins Medicine researchers compared psychedelic experiences with near-death experiences that were not drug related and found notable similarities in people’s attitudes toward death.

Released: 24-Aug-2022 2:00 PM EDT
COVID antibody research conducted at VUMC lands national award
Vanderbilt University Medical Center

A long-acting antibody combination discovered at Vanderbilt University Medical Center (VUMC) that protects against COVID-19 in high-risk individuals, and which was optimized and developed by the global pharmaceutical company AstraZeneca, has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

17-Aug-2022 9:35 AM EDT
How near-death experiences and psychedelics alter attitudes about death
PLOS

Analysis of 3,192 experiences could inform clinical strategies to reduce end-of-life distress.

Released: 23-Aug-2022 10:30 AM EDT
CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea
Hackensack Meridian Health

JSF-2659, developed to be administered orally, could be a game changer in treating Neisseria gonorrhoeae, which is on the World Health Organization’s global list of “priority pathogens” for its resistance to existing drugs.

Newswise: Insight into Roundup® Weed Killer’s Neurological Impact – Collaborative Lab Makes Dramatic Findings
Released: 23-Aug-2022 8:05 AM EDT
Insight into Roundup® Weed Killer’s Neurological Impact – Collaborative Lab Makes Dramatic Findings
Nova Southeastern University

Taking research to the next step, a new study shows that Roundup® weed killer may have new dangers

   
Newswise:Video Embedded study-first-to-link-weed-killer-roundup-to-convulsions-in-animals
VIDEO
18-Aug-2022 11:30 AM EDT
Study First to Link Weed Killer Roundup® to Convulsions in Animals
Florida Atlantic University

A study is the first to link the use of the herbicide Roundup® to convulsions in animals. Glyphosate, the weed killer component in Roundup®, is the world’s most commonly used herbicide. Results showed that glyphosate and Roundup® increased seizure-like behavior in soil-dwelling roundworms and provides significant evidence that glyphosate targets GABA-A receptors. These communication points are essential for locomotion and are heavily involved in regulating sleep and mood in humans. What truly sets this research apart is that it was done at significantly less levels than recommended by the EPA and those used in past studies.

Released: 22-Aug-2022 3:45 PM EDT
Find expert commentary on the monkeypox outbreak here
Newswise

The latest research and expert commentary on the monkeypox outbreak.

Released: 22-Aug-2022 3:25 PM EDT
New insights into the mechanisms behind Crohn’s disease point to potential therapeutic target
Massachusetts General Hospital

Mutations within Speckled Protein 140 (SP140) are associated with an increased risk of Crohn’s disease

Released: 22-Aug-2022 3:05 PM EDT
Brentuximab vedotina puede mejorar la supervivencia general en pacientes con linfoma de Hodgkin
Mayo Clinic

Un estudio dirigido por los científicos del Centro Oncológico Integral de Mayo Clinic descubrió que la adición de brentuximab vedotina a la quimioterapia estándar mejora la supervivencia general de los pacientes con linfoma de Hodgkin, comparado con la administración de solo la quimioterapia estándar.

Released: 22-Aug-2022 3:05 PM EDT
Medicamento brentuximab vedotina pode melhorar a sobrevida geral de pacientes com linfoma de Hodgkin
Mayo Clinic

Um estudo conduzido por pesquisadores do Centro de Câncer da Mayo Clinic descobriu que adicionar o brentuximab vedotina ao tratamento quimioterápico padrão aumenta a taxa geral de sobrevida de pacientes com linfoma de Hodgkin, em comparação com o padrão de tratamento atual que usa somente a quimioterapia.

Released: 22-Aug-2022 3:05 PM EDT
دواء برنتوكسيماب فيدوتين قد يحسّن فرص النجاة لدى مرضى لمفومة هودجكيِن عموماً
Mayo Clinic

وجدت دراسة قادها باحثون من مركز مايو كلينك الشامل للسرطان أن إضافة دواء برنتوكسيماب فيدوتين إلى العلاج الكيميائي المعتاد يحسّن فرص النجاة لدى مرضى لمفومة هودجكيِن بشكل عام، بالمقارنة مع المعيار الحالي للعلاج الكيميائي وحده.

Released: 22-Aug-2022 3:05 PM EDT
Brentuximab vedotin可提高霍奇金淋巴瘤患者的总体存活期
Mayo Clinic

一项由妙佑医疗国际综合癌症中心的研究人员牵头的研究表明,相比目前单纯采用化疗的标准疗法,在标准化疗疗法中添加brentuximab vedotin可提高霍奇金淋巴瘤患者的总体存活期。

Released: 22-Aug-2022 1:05 PM EDT
Psychiatrists disagree with U.S. policy on psychoactive drugs
Ohio State University

A new national survey reveals considerable differences between psychiatrists’ perceptions about the safety and therapeutic value of certain psychoactive drugs and how those same drugs are categorized under U.S. policy.

Newswise: Sensor could help patients stay on top of their meds
15-Aug-2022 11:45 PM EDT
Sensor could help patients stay on top of their meds
American Chemical Society (ACS)

Lithium needs to be taken in just the right amount to be effective. Today, scientists report the development of a tiny sensor that detects lithium levels noninvasively from sweat on a fingertip in about 30 seconds. The researchers will present their results at ACS Fall 2022.

   
15-Aug-2022 11:45 PM EDT
Lupus pill shows promise in mice; clinical trial underway
American Chemical Society (ACS)

There’s no cure for lupus, an autoimmune disease that attacks organs. But today, scientists report they have begun phase 2 clinical trials with a pill containing a compound that, in mice, reverses organ damage and prevents death. They will present their results at ACS Fall 2022.

   
Released: 19-Aug-2022 4:10 PM EDT
Out-of-pocket cost of naloxone may keep many uninsured from using life-saving treatment
RAND Corporation

The cost of buying the opioid antidote naloxone is out of reach for many uninsured Americans, a hurdle that may keep the treatment from saving more people who overdose on opioids, according to a new RAND Corporation study.

Newswise: First in Nation: UC San Diego Health Offers Treatment for Hereditary Amyloidosis
Released: 18-Aug-2022 2:15 PM EDT
First in Nation: UC San Diego Health Offers Treatment for Hereditary Amyloidosis
UC San Diego Health

New medication now available at UC San Diego Health allows for less frequent visits for patients, helping improve quality of life.

Released: 18-Aug-2022 12:25 PM EDT
COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment
University of Minnesota Medical School

Published in the New England Journal of Medicine, researchers — led by the University of Minnesota Medical School and School of Public Health — have found that metformin, a commonly prescribed diabetes medication, lowers the odds of emergency department visits, hospitalizations, or death due to COVID-19 by over 40 percent; and over 50 percent if prescribed early in onset of symptoms.



close
3.34085